-
In an updated policy statement, the American Society for Reproductive Medicine says transgender status should not prevent a patient from accessing fertility preservation. Further, reproductive services should be offered to all interested transgender or nonbinary individuals, barring other disqualifying factors (based on empirical evidence as opposed to bias or stereotypes).
-
A shorter program could be more useful for smaller universities that may not have the resources available to implement a longer program.
-
By including ordinary people, researchers could create consent forms, and a consenting process, that is primarily suited to meeting the needs of potential participants.
-
Keep in mind the person who has who to digest informed consent information. Avoiding complex terminology could lead to better understanding among the laypeople who participate in clinical trials.
-
Some ethicists are unaware of how code status options are named and defined at their institutions. Researchers found that at some hospitals, code status options in the electronic medical record did not even match what was in the hospital policy. Ethics should be one of the experts in this area.
-
Researchers hope leaders can use these data to decide what resources to devote to ethics consultation.
-
Numerous real-life examples of artificial intelligence in healthcare already pose difficult ethical questions: Informed consent, patient privacy, transparency, allocation, and safety are a few. The authors of a recent paper argued artificial intelligence-related ethics training should begin in medical school.
-
Despite ongoing efforts to address disparities in Alzheimer’s disease and dementia care, much work remains. The authors of a recent report identified some of the barriers diverse populations are facing in accessing and receiving dementia care.
-
The first new Alzheimer’s drug to be approved in almost 20 years has sparked a major ethical controversy, leading to protest resignations, criticism, qualifying statements, and even calls for investigations.
-
Usually, there is plenty of time for patients or families to decide if they want to be involved in a clinical trial, and there is adequate time for a thorough informed consent process. It’s a bit different in the ICU.
